6533b7ddfe1ef96bd12754b2
RESEARCH PRODUCT
Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
Elena CabezudoCristina EncinasIsabel VicuñaPaz RibasBelén IñigoPascual FernándezMª ÁNgeles RuízYolanda GonzálezMercedes GironellaJavier De La RubiaMario LegardaMaría J CejalvoAngel RamirezJesús MartínEugenia AbellaAna García-feriasubject
MaleOncologymedicine.medical_specialtymedicine.medical_treatmentDisease-Free SurvivalRecurrenceRenal DialysisMultiple myelomaDaratumumabInternal medicinemedicineHumansIn patientSingle agentRelapseDialysisMultiple myelomaAgedRetrospective Studiesrelapsebusiness.industryAntibodies MonoclonalDaratumumabRefractory Multiple MyelomaHematologyMiddle Ageddaratumumabmedicine.diseasemultiple myelomaSurvival RatedialysisFemalebusinessDialysisdescription
Correspondence.
year | journal | country | edition | language |
---|---|---|---|---|
2019-12-02 | British Journal of Haematology |